Iniquitous
发表于 2025-3-25 04:45:15
http://reply.papertrans.cn/19/1819/181820/181820_21.png
Indent
发表于 2025-3-25 09:08:21
http://reply.papertrans.cn/19/1819/181820/181820_22.png
Mobile
发表于 2025-3-25 14:51:54
http://reply.papertrans.cn/19/1819/181820/181820_23.png
违反
发表于 2025-3-25 16:36:34
http://reply.papertrans.cn/19/1819/181820/181820_24.png
AORTA
发表于 2025-3-25 21:39:01
http://reply.papertrans.cn/19/1819/181820/181820_25.png
Iniquitous
发表于 2025-3-26 03:43:58
http://reply.papertrans.cn/19/1819/181820/181820_26.png
亲爱
发表于 2025-3-26 04:33:32
Randomized Phase II Designs efficiency to handle the complexity of immunotherapies and targeted therapies that may involve binary, survival, ordinal, co-primary and multiple endpoints. A two-stage screened selection design (SSD) for randomized trials but without the control treatment is also introduced. Software to implement these designs are described.
妨碍议事
发表于 2025-3-26 10:32:42
Introduction to Basket Trialscorporation of precision medicine into clinical trials. This chapter introduces several frequentist and Bayesian designs for basket trials, with a special focus on borrowing information across cancer types using Bayesian hierarchical model approaches. Software for some designs are described.
mortgage
发表于 2025-3-26 16:24:03
lation study, proof-of-concept trials, and confirmatory studies with registrational. The book includes real-life examples and software to facilitate practitioners to learn and use the designs in practice..978-981-19-8467-9978-981-19-8176-0
鲁莽
发表于 2025-3-26 18:33:23
ive designs, such as model-assisted designs.Including many r.This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-esca